Zydus Lifesciences gets WHO prequalification for Typhoid Vi conjugate vaccine
Zydus Lifesciences Ltd. on Wednesday (October 23, 2024) said it has received in-principle acceptability from the World Health Organisation (WHO) for its Typhoid Vi conjugate vaccine, ZyVac TCV making it eligible for purchase by United Nations procurement agencies. ZyVac TCV is indigenously developed and manufactured at the Zydus Biotech Park, Ahmedabad and is indicated for…
Read More “Zydus Lifesciences gets WHO prequalification for Typhoid Vi conjugate vaccine” »